2015
DOI: 10.9734/jsrr/2015/11168
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Low-dose Orlistat (60 mg Twice Daily) on Weight-loss and Markers of Metabolic Disease in Obese Subjects: A Preliminary Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
3
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 5 publications
1
3
0
Order By: Relevance
“…For policosanol, it has been suggested a mild inhibition of the HMG-CoA reductase, but this action has not been confirmed [24] . Returning to explain the unforeseen exciting results of our study, it appears likely that while monacolin K with its statin-like mechanism has induced a reduction of total-Ch (and well of non-HDL Ch) around 10-20% at the most, as widely reported in other papers [24][25] as well as in our experience with other nutraceuticals [21] ; remains to be understood how and why we have reached a so great decrease of total -CH in comparison with other trials, not justified by the lower LDL-Ch decrease and the contemporary parallel decrease of non-HDL Ch.…”
Section: Discussionsupporting
confidence: 81%
See 3 more Smart Citations
“…For policosanol, it has been suggested a mild inhibition of the HMG-CoA reductase, but this action has not been confirmed [24] . Returning to explain the unforeseen exciting results of our study, it appears likely that while monacolin K with its statin-like mechanism has induced a reduction of total-Ch (and well of non-HDL Ch) around 10-20% at the most, as widely reported in other papers [24][25] as well as in our experience with other nutraceuticals [21] ; remains to be understood how and why we have reached a so great decrease of total -CH in comparison with other trials, not justified by the lower LDL-Ch decrease and the contemporary parallel decrease of non-HDL Ch.…”
Section: Discussionsupporting
confidence: 81%
“…The effects of berberine on lipid and glucose metabolism [17,[23][24][35][36][37][38][39] have been reported for many decades by Chinese medicine; furthermore, the synergistic effect derived from the interaction between monacolin and berberine on cholesterol reduction is a defined assumption so far [17,[23][24] . Conceivably, the complementary action of berberine and monacolin has very likely determined the concurrent heavy decrease of total-and non-HDL cholesterol in our patients by removing lipids (chiefly cholesterol) vehicolated by LDL as well VLDL lipoproteins [21] .…”
Section: Discussionmentioning
confidence: 95%
See 2 more Smart Citations